AO
Advisor OS’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.12M | Buy |
16,811
+412
| +3% | +$76.5K | 0.31% | 51 |
|
2025
Q1 | $3.44M | Buy |
16,399
+1,331
| +9% | +$279K | 0.39% | 42 |
|
2024
Q4 | $2.68M | Sell |
15,068
-419
| -3% | -$74.5K | 0.31% | 60 |
|
2024
Q3 | $3.06M | Buy |
15,487
+1,070
| +7% | +$211K | 0.3% | 58 |
|
2024
Q2 | $2.47M | Buy |
14,417
+215
| +2% | +$36.9K | 0.27% | 65 |
|
2024
Q1 | $2.59M | Buy |
14,202
+1,024
| +8% | +$186K | 0.3% | 62 |
|
2023
Q4 | $2.04M | Buy |
13,178
+516
| +4% | +$80K | 0.27% | 71 |
|
2023
Q3 | $1.89M | Buy |
12,662
+1,514
| +14% | +$226K | 0.28% | 64 |
|
2023
Q2 | $1.5M | Sell |
11,148
-6,827
| -38% | -$920K | 0.25% | 75 |
|
2023
Q1 | $2.86M | Sell |
17,975
-168
| -0.9% | -$26.8K | 0.69% | 31 |
|
2022
Q4 | $2.93M | Buy |
18,143
+3,602
| +25% | +$582K | 0.78% | 29 |
|
2022
Q3 | $1.95M | Sell |
14,541
-265
| -2% | -$35.6K | 0.59% | 38 |
|
2022
Q2 | $2.27M | Buy |
14,806
+612
| +4% | +$93.7K | 0.66% | 33 |
|
2022
Q1 | $2.3M | Sell |
14,194
-1,044
| -7% | -$169K | 0.67% | 30 |
|
2021
Q4 | $2.06M | Buy |
15,238
+910
| +6% | +$123K | 0.42% | 61 |
|
2021
Q3 | $1.55M | Buy |
14,328
+369
| +3% | +$39.8K | 0.34% | 68 |
|
2021
Q2 | $1.57M | Buy |
13,959
+2,557
| +22% | +$288K | 0.33% | 60 |
|
2021
Q1 | $1.24M | Buy |
11,402
+1,011
| +10% | +$110K | 0.28% | 69 |
|
2020
Q4 | $1.11M | Buy |
10,391
+5,450
| +110% | +$584K | 0.3% | 48 |
|
2020
Q3 | $433K | Sell |
4,941
-2,015
| -29% | -$177K | 0.18% | 61 |
|
2020
Q2 | $683K | Buy |
+6,956
| New | +$683K | 0.41% | 51 |
|